Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trialsRelationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with <i>RAS</i> wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials, Published online: 17 July 2018; doi:10.1038/s41416-018-0165-zRelationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials

Source: British Journal of Cancer - July 16, 2018 Category: Cancer & Oncology Authors: Marc Peeters Timothy Price Julien Taieb Michael Geissler Fernando Rivera Jean-Luc Canon George Pentheroudakis Reija Koukakis Peter Burdon Salvatore Siena Source Type: research